NASDAQ:QIPT Quipt Home Medical (QIPT) Stock Price, News & Analysis $1.93 -0.18 (-8.53%) Closing price 04:00 PM EasternExtended Trading$1.93 0.00 (0.00%) As of 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Quipt Home Medical Stock (NASDAQ:QIPT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Quipt Home Medical alerts:Sign Up Key Stats Today's Range$1.88▼$2.0850-Day Range$1.40▼$2.3352-Week Range$1.35▼$4.07Volume467,410 shsAverage Volume369,210 shsMarket Capitalization$83.97 millionP/E RatioN/ADividend YieldN/APrice Target$2.85Consensus RatingBuy Company OverviewQuipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.Read More… Quipt Home Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks44th Percentile Overall ScoreQIPT MarketRank™: Quipt Home Medical scored higher than 44% of companies evaluated by MarketBeat, and ranked 437th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingQuipt Home Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Amount of Analyst CoverageQuipt Home Medical has only been the subject of 2 research reports in the past 90 days.Read more about Quipt Home Medical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Quipt Home Medical are expected to decrease in the coming year, from ($0.05) to ($0.13) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Quipt Home Medical is -11.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Quipt Home Medical is -11.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioQuipt Home Medical has a P/B Ratio of 0.78. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Quipt Home Medical's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.52% of the float of Quipt Home Medical has been sold short.Short Interest Ratio / Days to CoverQuipt Home Medical has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Quipt Home Medical has recently increased by 6.54%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldQuipt Home Medical does not currently pay a dividend.Dividend GrowthQuipt Home Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted4.52% of the float of Quipt Home Medical has been sold short.Short Interest Ratio / Days to CoverQuipt Home Medical has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Quipt Home Medical has recently increased by 6.54%, indicating that investor sentiment is decreasing significantly. News and Social Media1.1 / 5News SentimentN/A Search Interest1 people have searched for QIPT on MarketBeat in the last 30 days. MarketBeat Follows1 people have added Quipt Home Medical to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Quipt Home Medical insiders have not sold or bought any company stock.Percentage Held by Insiders13.40% of the stock of Quipt Home Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions42.85% of the stock of Quipt Home Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Quipt Home Medical's insider trading history. Receive QIPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quipt Home Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address QIPT Stock News HeadlinesQuipt Home Medical (QIPT) Gets a Buy from Stifel NicolausMay 24, 2025 | theglobeandmail.comQuipt Home Medical Corp.: Quipt Home Medical Confirms Receipt of Unsolicited Acquisition ProposalMay 21, 2025 | finanznachrichten.deTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.June 5, 2025 | Porter & Company (Ad)Quipt Home Medical Receives Acquisition Proposal from ForagerMay 21, 2025 | tipranks.comQuipt Home Medical Confirms Receipt of Unsolicited Acquisition ProposalMay 21, 2025 | financialpost.comQuipt Home Medical Confirms Receipt of Unsolicited Acquisition ProposalMay 21, 2025 | globenewswire.comQuipt signals margin stability and healthcare system expansion strategy amid revenue softnessMay 13, 2025 | msn.comQuipt Home Medical Corp.: Quipt Home Medical Reports Fiscal Second Quarter 2025 ResultsMay 13, 2025 | finanznachrichten.deSee More Headlines QIPT Stock Analysis - Frequently Asked Questions How have QIPT shares performed this year? Quipt Home Medical's stock was trading at $3.05 at the start of the year. Since then, QIPT stock has decreased by 36.7% and is now trading at $1.93. View the best growth stocks for 2025 here. How were Quipt Home Medical's earnings last quarter? Quipt Home Medical Corp. (NASDAQ:QIPT) posted its quarterly earnings data on Monday, May, 12th. The company reported ($0.07) earnings per share for the quarter, missing analysts' consensus estimates of $0.02 by $0.09. The firm had revenue of $57.40 million for the quarter, compared to analyst estimates of $88.29 million. Quipt Home Medical had a negative trailing twelve-month return on equity of 6.70% and a negative net margin of 2.90%. Read the conference call transcript. Who are Quipt Home Medical's major shareholders? Top institutional shareholders of Quipt Home Medical include Kanen Wealth Management LLC (6.89%), Royce & Associates LP (4.53%), Russell Investments Group Ltd. (2.25%) and Pale Fire Capital SE (0.57%). View institutional ownership trends. How do I buy shares of Quipt Home Medical? Shares of QIPT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Quipt Home Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Quipt Home Medical investors own include Invesco QQQ (QQQ), SPDR S&P 500 ETF Trust (SPY), SPDR Dow Jones Industrial Average ETF Trust (DIA), Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD) and Tesla (TSLA). Company Calendar Last Earnings5/12/2025Today6/05/2025Next Earnings (Estimated)8/13/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryHealthcare Current SymbolNASDAQ:QIPT CIK1540013 Webwww.protechhomemedical.com Phone859-878-2220FaxN/AEmployees800Year FoundedN/APrice Target and Rating Average Stock Price Target$2.85 High Stock Price Target$4.00 Low Stock Price Target$1.70 Potential Upside/Downside+48.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.21) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$6.76 million Net Margins-2.90% Pretax Margin-2.57% Return on Equity-6.70% Return on Assets-2.94% Debt Debt-to-Equity Ratio0.74 Current Ratio1.22 Quick Ratio0.87 Sales & Book Value Annual Sales$240.85 million Price / Sales0.35 Cash Flow$0.75 per share Price / Cash Flow2.56 Book Value$2.47 per share Price / Book0.78Miscellaneous Outstanding Shares43,507,000Free Float37,317,000Market Cap$83.75 million OptionableOptionable Beta0.56 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:QIPT) was last updated on 6/5/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredJunior Explorer Taps Into TSMC’s $165 Billion Chip CorridorThe chip war is moving underground. As the U.S. ramps up semiconductor production to outpace China, an unex...Capital Trends | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quipt Home Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quipt Home Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.